Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Greiner Bio-One

The Preanalytics division develops, manufactures and distributes venous blood collection devices for hospitals, labor... read more Featured Products: More products

Download Mobile App




Greiner Bio-One Launches New Safety Blood Collection Set

By LabMedica International staff writers
Posted on 25 Jun 2018
Greiner Bio-One (Kremsmünster, Austria) has made a new addition to its range of safety products and now offers its customers an even wider selection of safety blood collection sets with the launch of the VACUETTE SAFETY Winged Set.

Approximately one-third of all occupational incidents in healthcare involve needlestick injuries. More...
Nurses are particularly at a risk of being infected by blood-borne diseases such as hepatitis B, hepatitis C and HIV. The use safety products for taking blood samples lowers the risk of needlestick injuries.

Greiner Bio One develops, manufactures, and supplies specimen collection systems, and products for pharmaceutical substance screening. The company offers pre-analytical products for collecting and processing human samples, including venous and capillary blood collection systems, urine collection systems, blood collection systems for neonates and infants, safety products, accessories, transport lines, disposals, instruments, saliva collection and quantification systems, and others.

In response to the demand for its safety products, Greiner Bio One has expanded its existing range with the launch of the new VACUETTE SAFETY Winged Set. Each of the VACUETTE SAFETY Winged Sets is equipped with a safety mechanism, which offers three different options for activating it immediately after blood collection. The safety mechanism makes a clearly audible click to confirm that the needle is safely and irreversibly locked in the safety shield. In order to provide users with more choice, the safety blood collection set is available both with and without a pre-assembled blood culture holder. Additionally, its transparent product design provides optimal blood flow visibility.


Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Clinical Chemistry System
P780
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.